Company news
Xencor, Inc. news in 2023
Xencor, Inc.'s news releases, calls and decks from 2023, newest first.
Xencor to Present at the Piper Sandler 35th Annual Healthcare Conference
November 20, 2023
Xencor Sells Portion of Royalties and Milestones from Ultomiris® and Monjuvi® to OMERS Life Sciences for $215 Million
November 6, 2023
Xencor Reports Third Quarter 2023 Financial Results
November 6, 2023
Xencor Presents Preclinical Data from Multiple XmAb® Research Programs at the SITC Annual Meeting
November 2, 2023
Xencor to Host Third Quarter 2023 Financial Results Webcast and Conference Call on November 7, 2023
October 30, 2023
Xencor Announces Planned Retirement of Chief Financial Officer John Kuch
October 25, 2023
Xencor to Present Multiple Posters at the SITC Annual Meeting
September 26, 2023
Xencor Appoints Barbara J. Klencke, M.D., to Board of Directors
September 18, 2023
Xencor Reports Second Quarter 2023 Financial Results
August 2, 2023
Xencor to Host Second Quarter 2023 Financial Results Webcast and Conference Call on August 3, 2023
July 26, 2023
Xencor Presents Clinical Results from Phase 1a Study of XmAb®564 at the EULAR 2023 Congress
May 29, 2023
Xencor Reports First Quarter 2023 Financial Results
May 7, 2023
Xencor to Host First Quarter 2023 Financial Results Webcast and Conference Call on May 8, 2023
April 30, 2023
Xencor Appoints Nancy Valente, M.D., as Chief Development Officer
April 25, 2023
Xencor Highlights CD28 Bispecific Antibody Platform at AACR Annual Meeting 2023
April 16, 2023
Xencor to Present Preclinical Data from Novel XmAb® CD28 Bispecific Antibody Programs at the American Association for Cancer Research Annual Meeting 2023
March 13, 2023
Xencor Reports Fourth Quarter and Full Year 2022 Financial Results
February 22, 2023
Xencor to Report Fourth Quarter and Full Year 2022 Financial Results and Host Conference Call on February 23, 2023
February 15, 2023
Xencor to Present at the SVB Securities Global Biopharma Conference
February 6, 2023
Xencor Highlights 2023 Corporate Priorities and Provides Portfolio Updates
January 8, 2023
Caris Life Sciences and Xencor Expand Target Discovery Collaboration for Novel XmAb® Antibody Drug Candidates
January 4, 2023
Xencor to Present at the 41st Annual J.P. Morgan Healthcare Conference
January 3, 2023